• Journal of Veterinary Clinics
• /
• v.19 no.2
• /
• pp.219-224
• /
• 2002

Fifty six dogs diagnosed with intervertebral disk disease between January 1999 and August 2001 were reviewed to characterize signalments and prognosis. Seventy-five percent was chondrodystrophoid breeds (42 dogs). Mean age was 5.1$\pm$3.0 year-old and fifty-four percent had acute onset. Interspaces between eleventh thoracic vertebrae and fourth lumbar vertebrae were affected most commonly. Success rate of conservative treatment to dogs with paresis was 83% and that of operation to dogs with paralysis was 67%. Six dogs were recurred and 50% of them had recovered again. There was significant correlation between success rate of treatment and the degree of clinical signs but there was no significant correlation between success rate of treatment and rate of onset, status of clinical signs, duration of clinical signs.

• Journal of Veterinary Clinics
• /
• v.21 no.2
• /
• pp.140-142
• /
• 2004

Thirty four dogs presented with generalized progressive retinal atrophy(gPRA) from September 2002 to April 2004 were reviewed to characterize signalments and prevalence rate in Korea. Mean age was 6.3$\pm$2.7 years-old and 59% was less than six years old. The most prevalent breed was Miniature Schnauzer (50%) and the affected mean age was slightly earlier (4.4$\pm$1.1 years-old). However, there was no sex predisposition. Cataract was confirmed in 15 dogs (44%) and 67% was bilateral.

• Journal of Veterinary Clinics
• /
• v.30 no.4
• /
• pp.273-277
• /
• 2013

This study was performed to compare clinical and diagnostic imaging features between asymptomatic and symptomatic extrahepatic portosystemic shunts in dogs. The data of thirty patients diagnosed with extrahepatic PSS by multi-detector CT were reviewed, and the dogs were divided into asymptomatic (9/30) and symptomatic (21/30) groups. Signalments, hematologic results, liver size, morphologic classifications and main portal vein to abdominal aortic ratio (PV/AO) at the porta hepatis level from CT images were evaluated in two groups. Shih-tzu (5/9) was the most frequent breed in asymptomatic group, and various breeds were presented in symptomatic group. Mean age of asymptomatic group ($9.2{\pm}3.2$ years) was significantly higher than that of symptomatic group ($4.5{\pm}3.2$ years). The most morphologic form of shunt vessel was the splenophrenic shunt (16/30). PV/AO of asymptomatic group ($1.1{\pm}0.19$) was significantly higher than the values of symptomatic group ($0.55{\pm}0.19$). Clinical signs, hematologic results and diagnostic imaging findings of asymptomatic PSS are too nonspecific to suspect PSS. Therefore, considering of patient's age and CT examination with application of PV/AO ratio could be useful for the diagnosis of asymptomatic PSS.

• Journal of Veterinary Clinics
• /
• v.34 no.1
• /
• pp.13-17
• /
• 2017

This study evaluated the efficacy and safety to determine the therapeutic responses of oclacitinib in canine atopic dermatitis (CAD) and identified factors related to the therapeutic response. Overall, 13 dogs with CAD were treated with oclacitinib for 56 days. Owners and veterinarians assessed visual analog scale (VAS) scores of pruritus and dermatitis. The examined dogs were grouped according to treatment success and failure based on changes in the VAS scores. To identify factors related to the therapeutic responses of oclacitinib, signalments (breed, sex, age, and body weight), mean progression time of CAD, mean Owner and Veterinarian VAS scores at day 0, and preexisting infection rate were compared between the two groups. Among the 13 dogs, 7 (53.8%) met the criteria of treatment success. In the success group, the Owner VAS scores were significantly lower from day 6 to 56 compared with the score at day 0 (P < 0.05). Additionally, the Veterinarian VAS scores were significantly decreased at days 14 and 42 compared with the score at day 0 (P < 0.05). There were no changes in hematological indices after the administration of oclacitinib. The most common abnormality reported was otitis externa (30.8%), followed by pyoderma (23.1%), and vomiting (7.7%). Factors related to responses of oclacitinib were not identified. This study demonstrated that oclacitinib was safe and moderately effective in dogs with CAD. This is the first report of the clinical application of oclacitinib in South Korea.

• Journal of Veterinary Clinics
• /
• v.24 no.4
• /
• pp.479-485
• /
• 2007

A retrospective study of 94 hypercalcemic dogs was performed to find out most common causes that lead to hypercalcemia through investigating dogs referred to the Veterinary Teaching Hospital of Konkuk University from 2002 to 2004. During the study period, hypercalcemia was found in 94 dogs of 19 breeds, and they were evaluated as case group. Control group was made up of 94 dogs of 18 breeds without hypercalcemia admitted for the same study period. For general signalments, there were no significant differences between case and control group with the exception of age distribution. Shih-tzu(17.02%) and Yorkshire terrier(26.60%) was the most common breed in case and control group, respectively. The most common diseases associated with hypercalcemia were chronic renal failure (18.09%), acute renal failure(14.89%), and renal calculi(6.38%). Malignant neoplasia(lymphoma, hemangiosarcoma, chronic lymphocytic leukemia, mammary gland tumor, and multiple myeloma) and endocrinopathies(hyperadrenocorticism, hyperthyroidism, hypoadrenocorticism, and hypothyroidism) occupied 8.5% and 6.4%, respectively. This report is a first retrospective study of hypercalcemic dogs in South Korea.